Christopher Peetz, President and CEO at Mirum Pharmaceuticals, Inc. (MIRM), sold 7,344 shares at $19.26 ($141K) on 2021-10-01, disclosed to the SEC on 2021-10-01.
Open-market sale of $141k MIRM by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.26 | 3,672 | $71K | 50.0% |
| 2 | $19.26 | 3,672 | $71K | 50.0% |
| Total | $19.26 avg | 7,344 | $141K | 100% |
| Filing → |
| MIRM | SELL | 2026-07-08 | $2.4M | — | Filing → |
| MIRM | SELL | 2026-06-02 | $2.9M | — | Filing → |
| MIRM | SELL | 2026-03-17 | $7.5M | — | Filing → |